Framework Ventures
VC Fund
Toronto, Canada
Framework Ventures is a VC fund in Toronto focused on Blockchain and Cryptocurrency. They are a team of technologists, researchers and investors who buy assets of, who build for, and who participate in open crypto networks. At its core, Framework is a technology company, building products and services to support the open blockchain networks that they invest in. Framework was started in 2019.
- Total investments:
- 198
- Last investment:
- Lead investor:
- 58%
Last updated:
For AI agents: llms.txt
Industries Framework Ventures invests in
Stages Framework Ventures invests in
Countries Framework Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $2M–$14M
- Series A
- $6M–$48M
Investment Focus
Industry
- Blockchain 60 (30%)
- Cryptocurrency 45 (23%)
- Financial Services 27 (14%)
- Software 25 (13%)
- FinTech 22 (11%)
Stage
- Seed 82 (41%)
- Series A 33 (17%)
- Funding Round 22 (11%)
- Initial Coin Offering 7 (4%)
- Pre-Seed 5 (3%)
Country
- United States 52 (26%)
- Singapore 9 (5%)
- Australia 8 (4%)
- United Kingdom 7 (4%)
- Canada 4 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Brandon Potts
Partner
|
Partner | Total investments: 17 | Find email | |
John DiCerbo
Chief Financial Officer / Chief Compliance Officer
|
Chief Financial Officer / Chief Compliance Officer | Total investments: 0 | Find email | |
Michael Anderson
Co-Founder
|
Co-Founder | Total investments: 32 | Find email | |
Roy Learner
Partner
|
Partner | Total investments: 8 | Find email | |
Vance Spencer
Co-Founder
|
Co-Founder | Total investments: 15 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Spearbit
|
Spearbit connects independent security experts to Web3 projects that need them.The company offers a range of services, including expert-conducted security reviews and ongoing security reviews through retainer agreements. These services provide clients with an operational layer, freeing them from time-consuming administrative tasks and clientsourcing and due diligence. | $8M / Venture - Series Unknown / Jul 30, 2026 | |
TVL Capital
|
TVL Capital operates as a specialized financial infrastructure firm focused on developing Chain-Traded Products (CTPs). The core business model centers on issuing, distributing, and managing institutional-grade structured financial products directly on blockchain networks. By replacing legacy financial rails with smart contract mechanics, thecompany enables sophisticated investment strategies with increased programmability and transparency. Their value proposition relies on establishing direct, regulatory-compliant distribution channels that bridge traditional capital market issuers with decentralized ecosystems. | $5M / Seed / Jun 08, 2026 | |
Mecka AI
|
Mecka AI is a data infrastructure company that builds large scale human datasets and tools to train and deploy AI and robotics systems. | $60M / Series A / Jun 01, 2026 | |
|
Checker
|
$8M / Seed / May 19, 2026 | ||
Midas
|
Midas is a cryptocurrency application that allows users to sell and invest in cryptocurrency and tokens. | $50M / Series A / Mar 30, 2026 | |
Ascent Funding
|
Ascent offers students opportunities to pay for higher education with or without a cosigner. It encourages transparency and financial wellness by incorporating financial education into the application process, preserving the notion that education is an investment where students and families should understand the return on their investment relativeto the cost. | $45M / Series C / Feb 19, 2026 | |
NovaBay Pharmaceuticals
|
Going Beyond Antibiotics®Developing Anti-Infective Compounds Effective Against Bacteria, Viruses and Fungi.NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company developing products for the eye care market. We are currently focused primarily on commercializing prescription Avenova® for managing hygiene of the eyelids and lashes in theUnited States.Avenova is the only eye care product formulated with a proprietary, stable and pure form of hypochlorous acid called Neutrox®. By replicating the anti-microbial chemicals used by white blood cells to fight infection, Neutrox has proven in laboratory testing to have broad antimicrobial properties. Avenova with Neutrox removes debris from the skin on eyelids and lashes without burning or stinging.We have developed additional commercial products containing Neutrox, including our NeutroPhase® Skin and Wound Cleanser for wound care and CelleRx® for the dermatology market. We have partnerships for NeutroPhase in the U.S. as well as select overseas markets, most notably China.In addition to our Neutrox family of products, we have also synthesized and developed a second category of novel compounds aimed at harnessing the power of white blood cell chemistry to address the global, topical anti-infective market. This second product category includes auriclosene, our lead clinical-stage Aganocide® compound, which is a patented, synthetic molecule with a broad spectrum of activity against bacteria, viruses and fungi. | $134M / Post-IPO Equity / Jan 16, 2026 | |
Obex
|
Obex helps to fund stablecoin projects backed by compute, energy and fintech credit on the Sky protocol. | $37M / Venture - Series Unknown / Nov 18, 2025 | |
|
Obex
|
Obex helps to fund stablecoin projects backed by compute, energy and fintech credit on the Sky protocol. | $37M / Venture - Series Unknown / Nov 18, 2025 | |
Allora Labs
|
Allora Labs is a blockchain-based protocol that incentivizes experts to answer subjective questions honestly and captures the value of truth. Its first product aims to provide an efficient price-discovery mechanism for NFTs by paying experts for honest appraisals unlocking new opportunities for experts and enabling a number of powerful new DeFiprimitives. | $35M / Venture - Series Unknown / Oct 21, 2025 | |
| See all 198 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Framework Ventures invest in?
Framework Ventures invests primarily in Blockchain, Cryptocurrency and Financial Services startups, most often at Seed and Series A stage. Most of the 198 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Framework Ventures's check size?
Framework Ventures typically joins rounds of $2M–$14M at Seed and $6M–$48M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Framework Ventures participates in.
How do I contact Framework Ventures?
Public channels for Framework Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Framework Ventures?
The team at Framework Ventures includes Brandon Potts (Partner), John DiCerbo (Chief Financial Officer / Chief Compliance Officer) and Michael Anderson (Co-Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
